Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
623.00    5.00 (0.81%)
Bid:
624.00
Ask:
628.00
Spread: 4.00 (0.641%)
Market Cap: £503.65m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

23 Apr 2021 07:00

RNS Number : 4183W
Bloomsbury Publishing PLC
23 April 2021
 

BLOOMSBURY PUBLISHING PLC

("Bloomsbury" or "the Company")

New Bloomsbury acquisition strengthens Bloomsbury Digital Resources division

23 April 2021

Bloomsbury Publishing Plc (LSE: BMY), the leading independent publisher, today announces that it has signed a sale and purchase agreement for the acquisition of certain assets of Red Globe Press ("RGP"), the academic imprint, from Macmillan Education Limited, a part of Springer Nature Group. The consideration is £3.7 million, of which £2.1 million will be satisfied in cash at completion and up to £1.6 million will be paid on or post-completion, subject to assignment of certain contracts.

RGP specialises in high-quality publishing for Higher Education students globally in Humanities and Social Sciences, Business and Management, and Study Skills. RGP has a backlist of more than 7,000 titles and publishes more than 100 new titles per year, with content including digital platforms, textbooks, research-driven materials and general academic publishing. The acquired RGP titles are a good strategic fit, strengthen Bloomsbury's existing academic publishing, and establish new areas of academic publishing in Business and Management, Study Skills and Psychology. RGP's three digital products will be migrated to Bloomsbury Digital Resources' own platform and its content added to Bloomsbury Collections. The business will operate within Bloomsbury's Academic and Professional division.

RGP generated £9.6 million* of revenue in the year ended 31 December 2020, and profit before tax of £1.1 million, with gross assets of approximately £0.8 million. There are opportunities for profit enhancements following the integration of the business into Bloomsbury. In the remaining nine months of Bloomsbury's financial year ending 28 February 2022, RGP is expected to contribute approximately £6.0 million of revenue and £0.4 million of profit before tax, prior to integration and acquisition costs.

Nigel Newton, Chief Executive of Bloomsbury, commented:

"We are delighted to acquire the Red Globe Press list. Red Globe Press aligns well with our existing academic publishing and provides a gateway to new and attractive academic publishing areas. This move is another key step in the delivery of our strategic growth strategy, and continues our drive to grow our Non-Consumer business. Acquiring these complementary lists accelerates our digital growth and our significant presence in humanities and social sciences academic publishing."

Emma Bourne, Managing Director Curriculum and Higher Education, Macmillan Education, commented: "Following a strategic review of the business, we have decided to focus on our core markets of K-12 English Language Teaching and Curriculum. We are sure that Red Globe Press, its team of dedicated staff, and all its authors will flourish within Bloomsbury, where the imprint can continue to grow its excellent academic publishing." 

\* These numbers are unaudited.

 

For further information, please contact:

Bloomsbury Publishing Plc

Nigel Newton, Chief Executive

nigel.newton@bloomsbury.com

Penny Scott-Bayfield, Group Finance Director

penny.scott-bayfield@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Rebekah Chapman

bloomsbury@hudsonsandler.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.

Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forward‑looking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.

The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forward‑looking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.

References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUOSVRAAUSURR
Date   Source Headline
6th Jul 20186:30 pmRNSHolding(s) in Company
18th Jun 201812:50 pmRNSAnnual Financial Report
7th Jun 201810:33 amRNSBloomsbury author wins major prize
1st Jun 20185:03 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
18th May 20183:23 pmRNSBlock Listing Six Monthly Return
8th May 20187:00 amRNSBloomsbury and Spotify announce partnership
1st May 20186:25 pmRNSAcquisition of IB Tauris & Co. Limited
1st May 20187:00 amRNSAcquisition of IBT Tauris & Co. Limited
19th Apr 20187:00 amRNSBoard Appointment
19th Mar 20184:37 pmRNSTrading Update
21st Dec 20177:00 amRNSDirectorate Change
17th Nov 201711:44 amRNSBlock listing Interim Review
2nd Nov 201712:25 pmRNSHolding(s) in Company
24th Oct 20177:00 amRNSHalf-year Report
2nd Oct 20173:22 pmRNSHolding(s) in Company
22nd Sep 20177:00 amRNSInterim Results Date Change
5th Sep 20174:57 pmRNSDirector/PDMR Shareholding
11th Aug 20172:24 pmRNSDirector/PDMR Shareholding
28th Jul 201712:56 pmRNSDirector/PDMR Shareholding
28th Jul 201712:54 pmRNSDirector/PDMR Shareholding
28th Jul 201712:54 pmRNSDirector/PDMR Shareholding
28th Jul 201712:52 pmRNSDirector/PDMR Shareholding
20th Jul 20177:00 amRNSDirector/PDMR Shareholding
18th Jul 20171:19 pmRNSResults of voting on resolutions at the AGM
18th Jul 20177:00 amRNSTrading Statement
4th Jul 20172:45 pmRNSDirector/PDMR Shareholding
19th Jun 20179:55 amRNSAnnual Financial Report
16th Jun 20177:00 amRNSBoard Appointment
19th May 20174:44 pmRNS6 Month Blocklisting Return
18th May 20177:00 amRNSFinal Results
23rd Mar 20171:47 pmRNSHolding(s) in Company
20th Jan 20177:00 amRNSBoard Appointment
4th Jan 20177:15 amRNSEmployee Benefit Trust purchase of shares
13th Dec 20164:53 pmRNSDirector/PDMR Shareholding
13th Dec 20164:52 pmRNSDirector/PDMR Shareholding
13th Dec 20164:50 pmRNSDirector/PDMR Shareholding
13th Dec 20164:46 pmRNSDirector/PDMR Shareholding
18th Nov 201610:35 amRNSBlock Listing Six Monthly Return
1st Nov 20164:08 pmRNSHolding(s) in Company
1st Nov 20162:58 pmRNSHolding(s) in Company
27th Oct 20167:00 amRNSHalf-year Report
4th Oct 20164:35 pmRNSPrice Monitoring Extension
12th Sep 20164:30 pmRNSPro forma historic results
31st Aug 20163:09 pmRNSTotal Voting Rights
23rd Aug 20162:14 pmRNSApplication for Admission
16th Aug 20169:55 amRNSHolding(s) in Company
19th Jul 20161:24 pmRNSResults of voting on resolutions at the AGM
18th Jul 20163:15 pmRNSHolding(s) in Company
13th Jul 20167:00 amRNSCapital Markets Day and Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.